Obstructive Sleep Apnea (OSA) Devices Market: By Diagnostic Devices (Polysomnography Devices (PSG), Pulse Oximeters, and Actigraphy Devices), Therapeutic Devices (Positive Airway Pressure (PAP) Devices, Oxygen Devices, Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories) and Geography 2019-2030

The obstructive sleep apnea (OSA) devices market was valued at USD 4.1 billion in 2023 and is projected to grow at 6.5% CAGR over the forecast years to reach USD 6.4 billion by 2030. The obstructive sleep apnea (OSA) devices market is experiencing significant growth, driven by several factors such as the rising awareness of OSA's large pool of undiagnosed patients, and poor compliance with CPAP therapy. Obstructive Sleep Apnea (OSA) affects about 39 million adults in the U.S. and an estimated 936 million adults globally. However, due to a lack of awareness and non-specific symptoms, many cases go undiagnosed. With the global population aged 60 and above projected to reach 2 billion by 2050, the incidence of sleep disorders, particularly OSA, is rising. OSA affects 13% to 32% of individuals aged 65 and above. Sleep apnea is a serious sleep disorder that can lead to several health problems, including high blood pressure, heart disease, stroke, and diabetes. As public awareness of OSA grows, more people are being diagnosed and treated for the condition. This is driving the demand for OSA devices. The high cost of OSA devices and associated risks with oral appliances are the constraints that will hinder the market growth of obstructive sleep apnea (OSA) devices. The development of new and innovative OSA devices and the increasing adoption of home sleep testing are opportunities that have significant market growth by addressing existing constraints. Telemedicine for OSA diagnosis and treatment and focus on patient comfort and compliance are the trends.

Recent Developments in the Obstructive Sleep Apnea (OSA) Devices Market

• In August 2021, ResMed rolled out a new sleep apnea machine as companies raced to fill a void left by Philips' CPAP recall.
• In February 2021, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea, launched its new product O2Vent Optima, which is a highly effective and more convenient alternative for CPAP therapy.